A share price of Anavex Life Sciences Corporation [AVXL] is currently trading at $9.03, up 2.67%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The AVXL shares have lost -8.32% over the last week, with a monthly amount glided 0.78%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Anavex Life Sciences Corporation [NASDAQ: AVXL] stock has seen the most recent analyst activity on December 06, 2022, when Cantor Fitzgerald downgraded its rating to a Neutral and also revised its price target to $11 from $16. Previously, Berenberg started tracking the stock with Buy rating on June 23, 2022, and set its price target to $40. On September 23, 2021, BTIG Research initiated with a Buy rating and assigned a price target of $35 on the stock. H.C. Wainwright reiterated its Buy rating and increased its price target to $17 on December 16, 2020. Ladenburg Thalmann initiated its recommendation with a Buy and recommended $12 as its price target on September 28, 2020. In a note dated June 18, 2019, Janney initiated a Buy rating.
Anavex Life Sciences Corporation experienced fluctuations in its stock price throughout the past year between $5.22 and $14.44. Currently, Wall Street analysts expect the stock to reach $11 within the next 12 months. Anavex Life Sciences Corporation [NASDAQ: AVXL] shares were valued at $9.03 at the most recent close of the market. An investor can expect a potential return of 21.82% based on the average AVXL price forecast.
Analyzing the AVXL fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.34, Equity is -0.33 and Total Capital is -0.58.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Anavex Life Sciences Corporation [NASDAQ:AVXL] is 8.93. As well, the Quick Ratio is 8.93, while the Cash Ratio is 13.41.
